Literature DB >> 29193004

The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?

Bing Li1,2, Jinqin Liu2, Zefeng Xu1,2, Tiejun Qin1, Zhongxun Shi1, Zhen Song3, Huijun Huang1, Liwei Fang1, Hongli Zhang1, Lijuan Pan1, Naibo Hu1, Shiqiang Qu1, Yue Zhang1,2, Gang Huang4, Zhijian Xiao1,2.   

Abstract

Entities:  

Keywords:  gene mutation; myelodysplastic syndrome; prognostic model

Mesh：

Year:  2017        PMID： 29193004      PMCID： PMC9206821          DOI： 10.1111/bjh.15036

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  10 in total

1.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

2.  International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors:  P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

3.  Dynamics of clonal evolution in myelodysplastic syndromes.

Authors:  Hideki Makishima; Tetsuichi Yoshizato; Kenichi Yoshida; Mikkael A Sekeres; Tomas Radivoyevitch; Hiromichi Suzuki; Bartlomiej Przychodzen; Yasunobu Nagata; Manja Meggendorfer; Masashi Sanada; Yusuke Okuno; Cassandra Hirsch; Teodora Kuzmanovic; Yusuke Sato; Aiko Sato-Otsubo; Thomas LaFramboise; Naoko Hosono; Yuichi Shiraishi; Kenichi Chiba; Claudia Haferlach; Wolfgang Kern; Hiroko Tanaka; Yusuke Shiozawa; Inés Gómez-Seguí; Holleh D Husseinzadeh; Swapna Thota; Kathryn M Guinta; Brittney Dienes; Tsuyoshi Nakamaki; Shuichi Miyawaki; Yogen Saunthararajah; Shigeru Chiba; Satoru Miyano; Lee-Yung Shih; Torsten Haferlach; Seishi Ogawa; Jaroslaw P Maciejewski
Journal:  Nat Genet       Date:  2016-12-19       Impact factor: 38.330

Review 4.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

5.  Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

Authors:  Hagop Kantarjian; Susan O'Brien; Farhad Ravandi; Jorge Cortes; Jianqin Shan; John M Bennett; Alan List; Pierre Fenaux; Guillermo Sanz; Jean-Pierre Issa; Emil J Freireich; Guillermo Garcia-Manero
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

6.  Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

Authors:  Luca Malcovati; Ulrich Germing; Andrea Kuendgen; Matteo G Della Porta; Cristiana Pascutto; Rosangela Invernizzi; Aristoteles Giagounidis; Barbara Hildebrandt; Paolo Bernasconi; Sabine Knipp; Corinna Strupp; Mario Lazzarino; Carlo Aul; Mario Cazzola
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

7.  Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.

Authors:  A Nazha; M Narkhede; T Radivoyevitch; D J Seastone; B J Patel; A T Gerds; S Mukherjee; M Kalaycio; A Advani; B Przychodzen; H E Carraway; J P Maciejewski; M A Sekeres
Journal:  Leukemia       Date:  2016-05-20       Impact factor: 11.528

8.  Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.

Authors:  Moritz Gerstung; Andrea Pellagatti; Luca Malcovati; Aristoteles Giagounidis; Matteo G Della Porta; Martin Jädersten; Hamid Dolatshad; Amit Verma; Nicholas C P Cross; Paresh Vyas; Sally Killick; Eva Hellström-Lindberg; Mario Cazzola; Elli Papaemmanuil; Peter J Campbell; Jacqueline Boultwood
Journal:  Nat Commun       Date:  2015-01-09       Impact factor: 14.919

9.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
  10 in total
  5 in total

1.  Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Authors:  Zhongxun Shi; Bing Li; Huijun Huang; Tiejun Qin; Zefeng Xu; Hongli Zhang; Liwei Fang; Lijuan Pan; Naibo Hu; Shiqiang Qu; Gang Huang; Robert P Gale; Zhijian Xiao
Journal:  Br J Haematol       Date:  2019-03-05       Impact factor: 8.615

2.  [Mean corpuscular volume ≤100 fl was an independent prognostic factor in patients with myelodysplastic syndrome and bone marrow blast<5 percent].

Authors:  Z X Shi; T J Qin; Z F Xu; H J Huang; B Li; S Q Qu; N B Hu; L J Pan; D Liu; Y N Cai; Y D Zhang; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

3.  [Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis].

Authors:  J Y Wu; B Li; Y J Jia; P H Zhang; Z F Xu; T J Qin; S Q Qu; L J Pan; J Q Liu; X Yan; Y D Zhang; J Chen; J Y Gong; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14

4.  Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.

Authors:  Peng Zhang; Fuhong He; Jie Bai; Shohei Yamamoto; Shi Chen; Lin Zhang; Mengyao Sheng; Lei Zhang; Ying Guo; Na Man; Hui Yang; Suyun Wang; Tao Cheng; Stephen D Nimer; Yuan Zhou; Mingjiang Xu; Qian-Fei Wang; Feng-Chun Yang
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

5.  Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.

Authors:  Huijun Huang; Changlu Xu; Jie Gao; Bing Li; Tiejun Qin; Zefeng Xu; Sirui Ren; Yudi Zhang; Meng Jiao; Shiqiang Qu; Lijuan Pan; Naibo Hu; Jinqin Liu; Wenyu Cai; Yingnan Zhang; Dan Wu; Peihong Zhang; Robert Peter Gale; Gang Huang; Jiaxi Zhou; Lihong Shi; Zhijian Xiao
Journal:  Blood Cancer J       Date:  2020-08-14       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.